Differential expression of ADH4 between tumor and normal tissues in patients with non-small cell lung cancer has been observed, and can be used as a prognostic marker in patients with esophageal cancer (Peng et al., 2018). The gene discussed is ADH4; the disease is non-small cell lung carcinoma.